InnoCan Pharma Corporation (CSE:INNO)

InnoCan Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.26	5.01	3.89	4.95	11.05	3.36
Cash & Short-Term Investments	7.26	5.01	3.89	4.95	11.05	3.36
Cash Growth	39.81%	28.91%	-21.47%	-55.22%	229.30%	70.05%
Accounts Receivable	0.35	0.25	0.25	0.06	-	0
Other Receivables	0.38	0.29	0.42	0.18	0.17	0.11
Receivables	0.73	0.54	0.67	0.24	0.17	0.11
Inventory	2.6	3.32	1.75	1.13	0.51	0.43
Prepaid Expenses	0.05	0.07	0.34	0.45	0.72	0.31
Other Current Assets	0.3	0.22	0.17	0.1	0.08	0.07
Total Current Assets	10.94	9.15	6.8	6.88	12.52	4.28
Property, Plant & Equipment	0.1	0.11	0.14	0.1	0.05	0.06
Total Assets	11.04	9.26	6.94	6.98	12.58	4.33
Accounts Payable	0.23	0.19	0.11	0.1	0.05	0.53
Accrued Expenses	0.6	0.48	0.46	0.32	0.43	0.38
Current Portion of Leases	0	0.01	0.02	0.01	0	0.04
Other Current Liabilities	2.12	1.57	1.95	0.3	3.08	6.99
Total Current Liabilities	2.95	2.24	2.54	0.73	3.56	7.94
Long-Term Leases	-	-	0.01	0.02	-	0
Total Liabilities	4.35	2.24	2.55	0.75	3.56	7.94
Additional Paid-In Capital	40.29	40.08	37.18	34.77	33.67	10.96
Retained Earnings	-36.08	-34.91	-33.07	-28.37	-24.61	-14.56
Total Common Equity	4.21	5.17	4.1	6.39	9.06	-3.61
Minority Interest	2.48	1.86	0.28	-0.17	-0.04	-
Shareholders' Equity	6.69	7.02	4.39	6.23	9.01	-3.61
Total Liabilities & Equity	11.04	9.26	6.94	6.98	12.58	4.33
Total Debt	1.4	0.01	0.03	0.03	0	0.04
Net Cash (Debt)	5.86	5	3.85	4.91	11.05	3.32
Net Cash Growth	12.98%	29.75%	-21.60%	-55.53%	233.04%	74.49%
Net Cash Per Share	1.32	1.16	0.97	1.28	3.20	1.33
Filing Date Shares Outstanding	4.5	4.48	4.32	3.87	3.82	3.31
Total Common Shares Outstanding	4.5	4.46	4.12	3.84	3.82	2.9
Working Capital	7.98	6.91	4.26	6.15	8.96	-3.66
Book Value Per Share	0.93	1.16	1.00	1.66	2.37	-1.24
Tangible Book Value	4.21	5.17	4.1	6.39	9.06	-3.61
Tangible Book Value Per Share	0.93	1.16	1.00	1.66	2.37	-1.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.